DK0966277T3 - Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom - Google Patents
Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdomInfo
- Publication number
- DK0966277T3 DK0966277T3 DK98908904T DK98908904T DK0966277T3 DK 0966277 T3 DK0966277 T3 DK 0966277T3 DK 98908904 T DK98908904 T DK 98908904T DK 98908904 T DK98908904 T DK 98908904T DK 0966277 T3 DK0966277 T3 DK 0966277T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- nsaids
- prevent alzheimer
- alzheimer
- nsaid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/814,490 US6160018A (en) | 1995-03-13 | 1997-03-10 | Prophylactic composition and method for alzheimer's Disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0966277T3 true DK0966277T3 (da) | 2006-03-27 |
Family
ID=25215202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98908904T DK0966277T3 (da) | 1997-03-10 | 1998-03-04 | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1642575B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2001514655A (cg-RX-API-DMAC7.html) |
| AT (2) | ATE311865T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU6682298A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2283255C (cg-RX-API-DMAC7.html) |
| DE (2) | DE69841267D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0966277T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2253810T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998040061A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2163986B1 (es) * | 1999-07-13 | 2003-02-16 | Menarini Lab | Acidos-alfa-arilpropionicos y arilaceticos como inhibidores de la ciclooxigenasa-ii. |
| AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
| US20040127471A1 (en) * | 2002-09-17 | 2004-07-01 | Barry Reisberg | Methods of treating age associated memory impairment (AAMI), mild cognitive impairment (MCI), and dementias with cell cycle inhibitors |
| US7074826B2 (en) * | 2002-10-07 | 2006-07-11 | Encore Pharmaceuticals, Inc. | R-NSAID esters and their use |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| WO2005065069A2 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
| US20100173960A1 (en) * | 2006-09-21 | 2010-07-08 | Antonio Cruz | The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases |
| JP2010529101A (ja) | 2007-06-04 | 2010-08-26 | テックフィールズ インコーポレイテッド | 非常に速い皮膚及び膜浸透速度を有するnsaiaプロドラッグ及びその新規医薬使用 |
| CN108191846B (zh) | 2008-12-04 | 2021-08-20 | 于崇曦 | 高穿透性组合物及其应用 |
| HK1207562A1 (en) | 2012-01-18 | 2016-02-05 | 苏州泰飞尔医药有限公司 | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions |
| WO2015006489A1 (en) | 2013-07-11 | 2015-01-15 | University Of North Texas Health Science Center At Fort Worth | Blood-based screen for detecting neurological disease in primary care settings |
| EP3074525B1 (en) | 2013-11-26 | 2024-06-26 | University of North Texas Health Science Center at Fort Worth | Personalized medicine approach for treating cognitive loss |
| JP7412003B2 (ja) | 2018-01-18 | 2024-01-12 | ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワース | アルツハイマー病に罹患している患者の特定の亜集団を治療するためのnsaid及びドネペジルについてのコンパニオン診断 |
| EP4076424A1 (en) * | 2019-12-20 | 2022-10-26 | Basf Se | Composition for the treatment of amyloid-beta associated diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4028906A1 (de) * | 1990-09-12 | 1992-03-19 | Paz Arzneimittelentwicklung | Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| FR2687915B1 (fr) * | 1992-02-28 | 1995-05-05 | Rhone Poulenc Rorer Sa | Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r). |
| US5331000A (en) * | 1992-03-09 | 1994-07-19 | Sepracor Inc. | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
| US5382591A (en) * | 1992-12-17 | 1995-01-17 | Sepracor Inc. | Antipyretic and analgesic methods using optically pure R-ketorolac |
| US6160018A (en) * | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
| US5955504A (en) * | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
| US6255347B1 (en) * | 1996-06-21 | 2001-07-03 | Advanced Research And Technology Institute | Methods and compositions comprising R-ibuprofen |
-
1998
- 1998-03-04 CA CA002283255A patent/CA2283255C/en not_active Expired - Fee Related
- 1998-03-04 AU AU66822/98A patent/AU6682298A/en not_active Abandoned
- 1998-03-04 ES ES98908904T patent/ES2253810T3/es not_active Expired - Lifetime
- 1998-03-04 WO PCT/US1998/004176 patent/WO1998040061A1/en not_active Ceased
- 1998-03-04 JP JP53961998A patent/JP2001514655A/ja active Pending
- 1998-03-04 DE DE69841267T patent/DE69841267D1/de not_active Expired - Lifetime
- 1998-03-04 DE DE69832695T patent/DE69832695T2/de not_active Expired - Lifetime
- 1998-03-04 EP EP05026505A patent/EP1642575B1/en not_active Expired - Lifetime
- 1998-03-04 DK DK98908904T patent/DK0966277T3/da active
- 1998-03-04 AT AT98908904T patent/ATE311865T1/de active
- 1998-03-04 AT AT05026505T patent/ATE446748T1/de not_active IP Right Cessation
- 1998-03-04 EP EP98908904A patent/EP0966277B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998040061A1 (en) | 1998-09-17 |
| EP1642575A1 (en) | 2006-04-05 |
| CA2283255C (en) | 2007-01-02 |
| EP0966277B1 (en) | 2005-12-07 |
| DE69832695D1 (de) | 2006-01-12 |
| EP1642575B1 (en) | 2009-10-28 |
| EP0966277A1 (en) | 1999-12-29 |
| CA2283255A1 (en) | 1998-09-17 |
| DE69841267D1 (de) | 2009-12-10 |
| ATE446748T1 (de) | 2009-11-15 |
| JP2001514655A (ja) | 2001-09-11 |
| ES2253810T3 (es) | 2006-06-01 |
| DE69832695T2 (de) | 2006-09-14 |
| AU6682298A (en) | 1998-09-29 |
| ATE311865T1 (de) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE446748T1 (de) | Verwendung von r-carprofen zur vorbeugung der alzheimerschen krankheit | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| ID24487A (id) | Senyawa-senyawa benzosikloheptatiofen | |
| FI912621A7 (fi) | Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä | |
| BR0002073A (pt) | Processo para a preparação de um composto quiral | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| FI885346L (fi) | Ergolinderivat, som foerhindrar parkinsons sjukdom. | |
| IT1302243B1 (it) | Sintesi dell'1,1,1,3,3-pentafluoropropano. | |
| FR2684543B1 (fr) | Ligament artificiel, notamment pour la cheville. | |
| DE69808440D1 (de) | Verwendung von (+)mefloquine zur behandlung von malaria | |
| DE60128100D1 (de) | Analgetisches arzneimittel | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| DZ1576A1 (fr) | Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione. | |
| DK0424156T3 (da) | Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser | |
| FI912622A7 (fi) | Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä | |
| WO2000010554A3 (en) | Methods and compositions employing optically pure s(+) vigabatrin | |
| ITTO20000674A0 (it) | Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca. | |
| WO2002099422A3 (en) | Individualization of therapy with alzheimer's disease agents | |
| DK0896822T3 (da) | 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister | |
| IT1296613B1 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
| EE200200215A (et) | 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks | |
| SE9501773D0 (sv) | New use | |
| MXPA02002486A (es) | Uso de dexrazoxano para tratar la psoriasis. | |
| FR2680953B1 (fr) | Semelle deodorante, antibacteries, hydrothermique jetable. | |
| NO970190D0 (no) | Preparat til behandling av Parkinsons sykdom |